Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!
The Biologics Global
Market Report 2022-31 by The Business Research Company describes and explains
the global biologics market and covers 2016 to 2021, termed the historic
period, and 2022 to 2026, termed the forecast period, along with further
forecasts for the period 2026-2031. The report evaluates the market across each
region and for the major economies within each region.
The Biologics
Global Market Opportunities And Strategies Report covers biologics market
drivers, biologics market trends, biologics market segments, biologics market
growth rate, biologics market major players, biologics market size and a
special focus on identifying the trends, opportunities, and strategies that can
lead to success.
Request for the report sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=792&type=smp
The Biologics Global
Market Opportunities And Strategies Report is the most comprehensive report
available on this market and will help gain a truly global perspective as it
covers 60 geographies in detail. O&S reports are available off the shelf
and can be delivered to clients on the day of purchase. The chapter on the
impact of COVID-19 gives valuable insights on supply chain disruptions,
logistical challenges, and other economic implications of the virus on the
market. The chapter also covers markets which have been positively affected by
the pandemic.
View more on the Biologics Market Report:
https://www.thebusinessresearchcompany.com/report/biologics-market
A key biologics market trend:
Companies in the
biologics market are generating high profit margins due to high prices of
biologics and their effectiveness. According to Statista, the profit margin in
Q2 2020 for a few of the US biologics companies are 99.22% for Bluebird Bio
Inc., 88.83% for Biogen, 86.82% for Asterias Biotherapeutics, and 82.71% for
Allergan. Biologics treatment being nearly 22 times costlier than small
molecule, is expected to generate a higher profit margin of around 40% in the
future. For instance, the Biologics segment of Biocon Limited, an India-based
biopharmaceutical company, reported 29% profit margins in the third quarter of
FY 2019-2020.
The report
covers the biologics market segments:
1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
2) By
Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores,
Others
3) By Route Of
Administration: Oral, Parenteral, Others
4) By Drug
Classification: Branded Drugs, Generic Drugs
5) By Mode Of
Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
About The Business Research Company:
The Business
Research Company is a market intelligence firm that excels in company, market,
and consumer research. Located globally it has specialist consultants in a wide
range of industries including manufacturing, healthcare, financial services,
chemicals, and technology. It has offices in the UK, the US and India and
a network of trained researchers in 28+ countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check us out on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
Blog: http://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
No comments:
Post a Comment